ABO Blood Type and Short‐Term Mortality in Patients With Infection‐Associated Disseminated Intravascular Coagulation

Simon Flæng,Asger Granfeldt,Kasper Adelborg,Henrik Toft Sørensen
DOI: https://doi.org/10.1111/ejh.14329
2024-10-29
European Journal Of Haematology
Abstract:Background Disseminated intravascular coagulation (DIC) is a devastating disease of the coagulation system. We examined the association between ABO blood type and short‐term mortality in patients with infection‐associated DIC. Methods The study cohort was drawn from the Danish Disseminated Intravascular Coagulation (DANDIC) cohort. Our subcohort was restricted to patients with infection‐associated DIC. All‐cause 30‐day and 90‐day mortality were computed by Kaplan–Meier estimates and odds ratios between ABO blood types were examined using logistic regression analysis adjusted for age, sex, comorbidity, and location of infection. Blood type O was used as a reference. Results The DANDIC cohort included 3023 patients with DIC. Among these, 1853 (61%) had infection‐associated DIC. Data on ABO blood type were unavailable in 34 patients (1.8%), who were excluded. The median age was 68 years and 58.2% were males. The 30‐day mortality ranged between 38.6% and 42.5% and the 30‐day mortality odds ratios were 1.15 (95% confidence interval (CI), 0.92–1.42) for blood type A; 0.84 (95% CI, 0.49–1.43) for AB; and 0.95 (95% CI, 0.67–1.33) for B compared to blood type O. Conclusions We found no clinically meaningful difference in short‐term mortality between the various ABO blood types in patients with infection‐associated DIC.
hematology
What problem does this paper attempt to address?